Skip to main content
Clinical Trials/NL-OMON48792
NL-OMON48792
Completed
Not Applicable

Evolution of mitochondrial dysfunction and hypermetabolic inflammatory status in septic Intensive Care Unit patients - Mitochondria Intensive Care (MIC)

Wageningen Universiteit0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
blood poisoning
Sponsor
Wageningen Universiteit
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Septic ICU patients:
  • \- 18\+ years of age
  • \- Diagnosed with sepsis, not origniated from the urinary system
  • Control patients:
  • \- Short\-stay hospitalised patients (e.g. admission for one day), or patients
  • admitted to the outpatient clinic of Gelderse Vallei Hospital
  • \- Free of sepsis
  • \- Metabolically healthy
  • \- Age (\+/\- 2 years) and gender\-matched

Exclusion Criteria

  • \*Only applicable for septic ICU patients
  • \*\*Comprehensively described in appendix of the protocol
  • (All pre\-ICU admission notes are not applicable to control patients), •
  • Patients referred from another ICU
  • Patients with a haemoglobin level lower than 5,5 mmol/lL\*
  • Patients with a history of solid organ or bone marrow transplant
  • Patients with active autoimmune disease involving the lung, heart, liver,
  • small or large intestine, or neuromuscular system (e.g., myasthenia gravis,
  • multiple sclerosis) AND currently requiring systemic immunosuppressive therapy
  • Patients whom experienced a significant medical or surgical event leading to

Outcomes

Primary Outcomes

Not specified

Similar Trials